<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 57-year-old man underwent an autologous hematopoietic stem cell transplant for mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in August 1999 </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001903'>Anemia</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> appeared in November 2001 </plain></SENT>
<SENT sid="2" pm="."><plain>He was diagnosed with further hematological examination as having <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> following secondary <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>He received the allogeneic hematopoietic stem cell transplant from his HLA DRB1 locus mismatched brother in May 2002 </plain></SENT>
<SENT sid="4" pm="."><plain>The nonmyeloablative preparative regimen consisted of fludarabine 30mg/m2 for 6 days and <z:chebi fb="0" ids="28901">busulfan</z:chebi> 4mg/kg for 2 days </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001880'>Eosinophilia</z:hpo>, decrease of lacrimal fluid and <z:hpo ids='HP_0001410'>liver dysfunction</z:hpo> appeared on Day 104 </plain></SENT>
<SENT sid="6" pm="."><plain>We diagnosed this as <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD and treated the patient with <z:chebi fb="2" ids="8378">prednisolone</z:chebi> 10 mg/day </plain></SENT>
<SENT sid="7" pm="."><plain>Thereafter, his <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD gradually improved </plain></SENT>
<SENT sid="8" pm="."><plain>He had <z:hpo ids='HP_0001945'>fever</z:hpo> and <z:hpo ids='HP_0003326'>myalgia</z:hpo> in the extremities and lumbar region with <z:hpo ids='HP_0003236'>elevated serum CPK</z:hpo> and aldolase in January 2003 </plain></SENT>
<SENT sid="9" pm="."><plain>Histological examination led to a diagnosis of <z:e sem="disease" ids="C0085655" disease_type="Disease or Syndrome" abbrv="">polymyositis</z:e> simultaneously with <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="2" ids="8378">Prednisolone</z:chebi> 50 mg/day as an initial dose was started for the <z:e sem="disease" ids="C0085655" disease_type="Disease or Syndrome" abbrv="">polymyositis</z:e> following which the <z:chebi fb="2" ids="8378">prednisolone</z:chebi> dose was gradually tapered off </plain></SENT>
<SENT sid="11" pm="."><plain>The <z:e sem="disease" ids="C0085655" disease_type="Disease or Syndrome" abbrv="">polymyositis</z:e> improved promptly after the administration of <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and remains in remission with a current maintenance program of <z:chebi fb="2" ids="8378">prednisolone</z:chebi> 5 mg/day </plain></SENT>
</text></document>